Next, we used the LASSO regression to further select six key regulators consisting of CCL19, ICOSLG, IL11, PTGES, TNFAIP3, and TRAF3IP3 (Figure 2C,D), and they were named the Immune Glioma Survival Signature (IGLoS signature). Here, TNFAIP3 is linked to central nervous system cancer.